Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease.
Ho Soo ChunMin Jong LeeJae Seung LeeHye-Won LeeBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnEun Young LeeJi-Hye KimSeung-Up KimPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
MAFLD might better identify subjects with CVD risk than NAFLD. Fibrosis assessment might be helpful for detailed prognostication in subjects with MAFLD.